"Overall, nanomedicines may present additional development and regulatory considerations compared with conventional medicines....there is no doubt that the field of nanomedicine is still at its early stage, with success stories few and far apart. Most nanomedicine research, while exciting and technically advanced, is in early stages of development and is only slowly being translated into clinical trials and medical practice."
"Although small-scale processes may achieve reproducibility with well characterized components, once beyond the early prototype, the reproducibility and consistency of the constructs remain a constant challenge for the scale-up and manufacturing process..."
Sound familiar????? And why should anybody believe NNVC is special -- because of the "early prototype" the National Institute of Health warns about relying on?
News 
Market Data 
Discover 
